Position in RPRX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$11,839,180
+$1,477,660 QoQ
Shares Held
211,150
-2.2% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
2.90%
of 13F equity value
Holder Rank
#142
of 646 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Inlet Private Wealth, LLC holds $11,866,180 across 2 Biotechnology names. RPRX ranks #1 (99.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
211,150 | $11,839,180 | |
| 2 | DYAI |
Dyadic International Inc
|
30,000 | $27,000 |
All Filings in RPRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,839,180 | 211,150 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $10,361,520 | 216,000 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $8,724,912 | 225,800 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $8,296,092 | 235,150 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $8,461,285 | 234,840 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $7,307,456 | 234,740 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $6,039,237 | 236,740 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $5,331,533 | 188,460 | Shares | Sole | 2024-10-16 | |
| No filing history on record for this holder in this stock. | ||||||